Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 25.02.19
Views: 575
Rating:

Prof Josep Llovet, Dr Richard Finn

The RESORCE trial was a pivotal Phase 3 trial evaluating the efficacy and safety of regorafenib as second-line systemic therapy in patients with advanced HCC.

Post-hoc analysis of this trial has been conducted by Dr Richard Finn and colleagues, which revealed that regorafenib provided benefit regardless of disease progression during prior sorafenib treatment.

Chaired by Professor Josep Llovet and featuring guest author Dr Richard Finn, this session explores the available data surrounding systemic treatment sequencing, and how this should impact your practice.

If you would like to receive CME credits for watching this video please visit Oncology Knowledge into Practice.

If you scroll down the page you will see a button asking you to complete a short evaluation and claim credit.

If you would like to register for free to receive similar education please visit www.onkip.com.

This independent educational activity is supported by an educational grant from Bayer Pharmaceuticals.

The educational content has been developed by Liberum IME and validated by an independent steering committee; Bayer Pharmaceuticals have had no influence on the content of this education.

Related videos

follow us

Core Surgical Training


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation